Omega Diagnostics Group PLC Investor results presentation
12 July 2018 - 4:00PM
RNS Non-Regulatory
TIDMODX
Omega Diagnostics Group PLC
12 July 2018
Omega Diagnostics Group PLC
("Omega" or "the Company" or the "Group")
Investor results presentation
Omega (AIM: ODX), the medical diagnostics company focused on
allergy, food intolerance and infectious disease, announces it will
be hosting an investor evening for all investors on Monday 6 August
2018, accompanying the full year results for the year ended 31
March 2018.
The event will take place in the Copper Bar, upstairs at Balls
Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.45pm
for a 5.00pm start. This will be followed by light refreshments,
and a chance to network.
The results presentation will be available on the Company
website shortly after the event. No new information will be
disclosed.
If you would like to register to attend the briefing, or require
further information, please contact Walbrook PR on 020 7933 8780 or
email omega@walbrookpr.com.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group Finance
Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/James Thompson (Corporate
Finance)
Camille Gochez/ Abigail Wayne
(Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAEAFXFFEDPEFF
(END) Dow Jones Newswires
July 12, 2018 02:00 ET (06:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024